BerandaABCL • NASDAQ
add
AbCellera Biologics Inc
Tutup sebelumnya
$4,87
Rentang hari
$4,76 - $4,92
Rentang tahun
$1,89 - $6,52
Kapitalisasi pasar
1,44 M USD
Volume Rata-Rata
5,39 jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 17,08 jt | 133,29% |
Biaya operasional | 27,46 jt | -54,13% |
Penghasilan bersih | -34,73 jt | 5,97% |
Margin laba bersih | -203,27 | 59,69% |
Penghasilan per saham | -0,12 | 7,69% |
EBITDA | -44,11 jt | 22,51% |
Tarif pajak efektif | 4,45% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 553,08 jt | -17,49% |
Total aset | 1,40 M | -0,74% |
Total liabilitas | 394,98 jt | 31,00% |
Total ekuitas | 1,01 M | — |
Saham yang beredar | 298,83 jt | — |
Harga terhadap nilai buku | 1,43 | — |
Tingkat pengembalian aset | -9,03% | — |
Tingkat pengembalian modal | -11,07% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -34,73 jt | 5,97% |
Kas dari operasi | -32,40 jt | -8,14% |
Kas dari investasi | -31,81 jt | -161,06% |
Kas dari pembiayaan | -3,38 jt | -227,31% |
Perubahan kas bersih | -66,83 jt | -370,13% |
Arus kas bebas | -61,07 jt | -43,54% |
Tentang
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Didirikan
2012
Kantor pusat
Situs
Karyawan
596
